Filed: 11/14/2025ACC: 0001315863-25-000800
📋 What this filing means
CRESTLINE MANAGEMENT, L.P. filed this quarterly 13F‑HR report disclosing 3 equity positions with a total reported market value of $58.09M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
3
Positions
$58.09M
Total AUM (reported)
6.22M
Total Shares
Allocation by class
COM$58.09M100.0%
Portfolio Concentration
Top 3$58.09M100.0%
Top 3 weight
100.0%
Top 10 weight
100.0%
Voting Authority Distribution
Total shares with voting rights: 6.22M
Sole
Full voting authority
6.22M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole3
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings3
Rows:
DENALI THERAPEUTICS INC
SOLEShares3.41M
TypeSH
Market value$49.52M
85.26%
Sole
3.41M
Shared
0.00
None
0.00
SANA BIOTECHNOLOGY INC
SOLEShares1.82M
TypeSH
Market value$6.46M
11.13%
Sole
1.82M
Shared
0.00
None
0.00
8X8 INC NEW
SOLEShares990.58K
TypeSH
Market value$2.10M
3.62%
Sole
990.58K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
DENALI THERAPEUTICS INCSOLE | COM | 3.41M | SH | $49.52M 85.26% | 3.41M | 0.00 | 0.00 |
SANA BIOTECHNOLOGY INCSOLE | COM | 1.82M | SH | $6.46M 11.13% | 1.82M | 0.00 | 0.00 |
8X8 INC NEWSOLE | COM | 990.58K | SH | $2.10M 3.62% | 990.58K | 0.00 | 0.00 |